Two FDA-Approved Drugs May Help Treat Alzheimer’s Symptoms
Dozens of drugs designed to target and clear beta-amyloid plaques in the brain have failed to prevent or halt the progression of Alzheimer’s disease….
Dozens of drugs designed to target and clear beta-amyloid plaques in the brain have failed to prevent or halt the progression of Alzheimer’s disease….
On Monday, revealed that a phase 3 study of brexpiprazole — brand name Rexulti — in Alzheimer’s patients showed that the drug for major…
The FDA approves a new, transdermal form of donepezil called Adlarity, a skin patch for treating Alzheimer’s symptoms. Experts say it could be easier…
In “The Ethicist,” writer Chuck Klosterman’s weekly column for The New York Times, a question was submitted about the use of black floor mats…
Clinicians have suspected that people with early-onset Alzheimer’s, which becomes symptomatic in people aged 65 or younger, tend to decline more rapidly than those…
What’s the difference between treating Alzheimer’s symptoms and modifying the disease? Despite decades of research, the underlying cause of Alzheimer’s continues to evade scientists….
Apathy is an extremely common symptom of Alzheimer’s. It impairs patients’ ability to socialize and maintain routines, activities that are central to preserving their…
Whether it be coping with the cognitive, behavioral or psychological symptoms of dementia, adapting caregiver strategies throughout the different stages of the illness is…
Caregiving expert Teepa Snow knows from experience: There isn’t a one-size-fits-all approach to guide caregivers of people with Alzheimer’s or related dementias. In her…
Roughly one in 10 people worldwide, or over 700 million people, will experience hearing loss by 2050, and research suggests it is the leading…
When Kathy Kenyon’s parents — both with early-stage dementia — moved to the Washington, D.C. area, it took months for medical records to be…
Instead of developing a new drug from the ground up — a time-consuming and costly process — experts say that repurposing medications could accelerate…
Acadia Pharmaceuticals said today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration regarding its supplemental New…
Difficulty communicating is among the earliest symptoms of dementia. People may begin having a hard time finding words in a conversation, and as the…
When we swallow, we use muscles to move food and liquid from our mouth all the way down to our stomach, and that requires…